Clinical Trials Browser

Phase EARLY_PHASE1 × Pancreatic Neoplasms × avelumab × Clear all

NCT03481920 2019-08-22

A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms